CEO message

Representative Director President and CEO Fuminori Yoshida

SymBio With the aspiration of "Symbiosis" as our starting point, we have promoted new drug development specializing in "Underserved Therapeutic Areas", for which medical needs are extremely high but treatments have not yet been established.
By making full use of our unique and outstanding drug discovery and development model, and with the support and strength of many of you who support us, we are steadily producing results in new drug development and realizing our goal of bringing treatments to the many treatment sites and to the patients who are waiting for them.
We are now looking toward the future as a global specialty pharmaceutical company, contributing to the medical care of the world and growing, and we are determined to keep moving forward to achieve this goal.